Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Nathan Reilly
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters; questions recorded in 7).
- Questions
- 7on tracked calls
- Challenge rate
- 0%none of 7 questionsLimited sample
- Companies
- 1questioned at least once
- Reporting periods
- 7with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 7 of 7 questions from 1 company
AMCRAmcor7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
You've highlighted you're expecting a return to organic growth.
Show response
PK framed calendar 2027 as the first clean year after the combination, with focus categories now >50% of the top line and growth synergies (broader product range, global reach, innovation) driving expected outperformance versus a market he now sees as more positive; near term he expects to move with the market.
Calendar 2026 Q1
Can you just talk to me about how that impacts your ability to deliver on the procurement and also the growth synergy targets into FY '27
Show response
PK emphasized Amcor's scale as big global buyer important to suppliers. Resin is only half of $10B raw materials; other half is non-resin direct spend plus $3B indirects. Supply-side margins may improve with inflation. Steve reaffirmed $260M year-2 synergies and roughly half flowing through 6-month stub period.
Calendar 2025 Q4
Can you just give us an update in terms of where you're focusing that investment, particularly with respect to some of your growth investments
Show response
Steve confirmed CapEx on track at $850-900M. Growth investment weighted toward focus market categories where differentiation and innovation drive value. Limited detail on specific projects or expected volume impact.
Calendar 2025 Q3
Can you give us an update on your exposure to private-label products
Show response
PK acknowledged expectation that value-seeking consumers would shift to private label. Amcor has good exposure in NA and Europe but is somewhat underrepresented relative to private-label market share. Identified as focus area for growth.
Calendar 2025 Q2
how are you thinking about the timing of potential growth investment or even share buybacks
Show response
Michael confirmed priority is delevering from 3.5x to 2.5-3x target range. FY2026 FCF drives to 3.1-3.2x before any divestiture proceeds. Portfolio optimization proceeds would go to further deleveraging. Share buybacks considered only once comfortably in range. Small bolt-on M&A possible later.
Calendar 2025 Q1
can you please talk to how your merged Flexible portfolio is positioned to respond to that shift in consumer behavior
Show response
PK noted packaging formats are similar for branded vs private label. Good private label participation in NA, with opportunities to expand in other regions.
Calendar 2024 Q3
how you're seeing the state of the consumer across your key end markets in both the U.S. and Europe
Show response
PK broke growth into three components: flat/slightly down consumer, improved customer performance (better price/volume balance, destocking over), and early signs of market share gains. Performance similar across NA and Europe.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| AMCR Amcor | 7 | 0%none of 7 questions |
- AMCRAmcor · 7 questions0%none of 7 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 1 | 0%none of 1 question | 1 |
| 2024 Q4 | No questions recorded | — | — |
| 2025 Q1 | 1 | 0%none of 1 question | 1 |
| 2025 Q2 | 1 | 0%none of 1 question | 1 |
| 2025 Q3 | 1 | 0%none of 1 question | 1 |
| 2025 Q4 | 1 | 0%none of 1 question | 1 |
| 2026 Q1 | 1 | 0%none of 1 question | 1 |
| 2026 Q2 | 1 | 0%none of 1 question | 1 |
- 2024 Q31 question · challenge rate 0% (none of 1 question) · 1 company
- 2024 Q4No questions recorded
- 2025 Q11 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q31 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q41 question · challenge rate 0% (none of 1 question) · 1 company
- 2026 Q11 question · challenge rate 0% (none of 1 question) · 1 company
- 2026 Q21 question · challenge rate 0% (none of 1 question) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Demand3
- Revenue Growth2
- Capital Allocation2
- Competitive Dynamics2
- Guidance Reliability1
- M&A1
- Cost Pressure1